Physician profile
Ellen Lynette Williams
NPI 1821882333
$1,118.79
in general payments reported to CMS, 2019-2025
14 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $296.33 | 2025 | |
| Boston Scientific Corporation | $218.89 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Cvrx, INC. | $104.39 | 2025 | Barostim Neo System |
| Abbvie INC. | $98.44 | 2025 | |
| Eisai INC. | $83.40 | 2025 | |
| Novo Nordisk INC | $66.94 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $46.84 | 2025 | Airsupra, Breztri |
| Ardelyx, INC. | $46.11 | 2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.28 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $39.69 | 2025 | |
| Insulet Corporation | $23.15 | 2025 | Omnipod |
| Tolmar, INC. | $18.47 | 2025 | Jatenzo |
| Corcept Therapeutics | $17.88 | 2025 | Korlym |
| Ibsa Pharma INC. | $15.98 | 2025 | Flector, Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.